United StatesKetorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL) single-dose vial (2 mL) manufactured by Aspiro Pharma Limited for Camber Pharmaceuticals, NDC 31722-307-25 (carton) / 31722-307-02 (vial), lots AS1240347A (exp 09/2026); AS1240144A (exp 05/2026); AS1240145A and AS1240146A (exp 06/2026); and AS1250295A (exp 05/2027). Aspiro Pharma Limited is recalling these lots nationwide in the United States because particulate matter identified as glass was found.
What's being recalled
Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx only, Mfd. for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Mfd. by: ASPIRO PHARMA LIMITED, Telangana - 502281, INDIA., U.S. Contact Number: 1-866-495-1995, NDC 31722-307-25 (Carton), 31722-307-02 (Vial label).
Recalling firm: Aspiro Pharma Limited, Siddipet (District), India.
How to identify it
Lot #: AS1240347A, Exp Date 09/2026; AS1240144A, Exp Date 05/2026; AS1240145A, AS1240146A, Exp Date 06/2026; AS1250295A, Exp Date 05/2027.
The hazard
Presence of Particulate Matter: Particulate matter identified as glass
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide within the United States
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)